News | Radiation Therapy | April 19, 2019

Multicenter study comparing SRS outcomes for pediatric versus adult AVM patients finds no appreciable differences

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients

April 19, 2019 — Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner of the Cerebrovascular Section Best Clinical Scientific Paper at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 13-17 in San Diego. Chen’s research investigated stereotactic radiosurgery for pediatric versus adult brain arteriovenous malformations (AVM). The aim of this international, multicenter, retrospective, matched-cohort study is to directly compare the outcomes after stereotactic radiosurgery (SRS) for brain AVM in pediatric versus adult patients.

Researchers performed a retrospective review of AVM patients who underwent SRS at eight institutions participating in the International Gamma Knife Research Foundation (IGKRF) from 1987-2014. Patients were categorized into pediatric (<18 years old) and adult (≥18 years old) cohorts, and matched in a 1:1 ratio using propensity scores. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage and no permanently symptomatic radiation-induced changes (RIC).

The outcomes following SRS for comparable AVMs in pediatric versus adult patients were not found to be appreciably different. SRS remains a reasonable treatment option for appropriately selected pediatric AVM patients who harbor a high cumulative lifetime hemorrhage risk. Age appears to be a poor predictor of AVM outcomes after SRS.

For more information: www.aans.org


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
Subscribe Now